Newsbenzinga
FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test
· Published
Article summary
The FDA's advisory committee will meet on September 23 to review the PMA application for GRAIL's Galleri multi-cancer early detection test.
An excerpt from the original article.
Comments —
Loading comments…